Elevance Health Inc. (NYSE: ELV) ended the first quarter of 2025 with better-than-expected financials. The company identified home health as one of its key revenue drivers. In Q1, Elevance hauled in $48.8 billion in operating revenue, a 15% year-over-year increase. Carelon, Elevance’s health care services arm, earned $16.7 billion in Q1, a 38% year-over-year increase. “Our revenue result reflects contributions from recent acquisitions, particularly in pharmacy services and home health, two areas critical to advancing our whole health strategy,” Mark Kaye, Elevance’s chief financial officer, said on the company’s Q1 earnings call.
Read the full article: Elevance Health Credits Home Health Acquisitions as Revenue Catalysts //
Source: https://homehealthcarenews.com/2025/04/elevance-health-credits-home-health-acquisitions-as-revenue-catalysts/